Cerecor reports final phase II efficacy data on CERC-002 in hospitalized COVID-19 patients March 3, 2021
Tocilizumab does not significantly improve clinical status in severe COVID-19 pneumonia March 3, 2021
Positive interim analysis data from ongoing FURI and CARES phase III trials of ibrexafungerp March 3, 2021
Initiation of phase II study of triple combination therapy for the treatment of chronic HBV March 1, 2021
RSS